Skip to main content

Pharmacoepidemiological Approaches in Health Care

  • Chapter
Pharmacy Practice Research Methods
  • 1640 Accesses

Abstract

Pharmacoepidemiology studies patterns of medicines use—also known as drug utilization research—which is an important component of pharmacy practice research. Pharmacoepidemiology also studies the relationship between treatment or exposure and outcomes in large populations under nonexperimental situations over time. This chapter provides an introduction to pharmacoepidemiology. It discusses the key concepts involved in studying the association between medicines and outcomes. These include forming a research question, considering sources of data, defining the study population, and defining drug exposures and outcomes. This chapter also discusses a range of study designs used in pharmacoepidemiological research including cohort studies, case-control design, within-subject methods, cross-sectional studies, ecological studies, and quasi-experimental designs. Frequently used metrics to understand drug utilization and medication adherence are also introduced. This chapter also draws on key challenges such as selection bias as well as commonly used analytical techniques to overcome these challenges.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adams AS, Zhang F, LeCates RF et al (2009) Prior authorization for antidepressants in Medicaid: effects among disabled dual enrollees. Arch Intern Med 169(8):750–756

    Article  PubMed Central  PubMed  Google Scholar 

  • Agency for Healthcare Research & Quality (2013) Linking data for health services research: a framework and guidance for researchers (a draft report)

    Google Scholar 

  • Andrade SE, Kahler KH, Frech F, Chan KA (2006) Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 15(8):565–574, discussion 575–567

    Article  PubMed  Google Scholar 

  • Austin PC, Mamdani MM, Juurlink DN, Hux JE (2006) Testing multiple statistical hypotheses resulted in spurious associations: a study of astrological signs and health. J Clin Epidemiol 59(9):964–969

    Article  PubMed  Google Scholar 

  • Avorn J (2004) The role of pharmacoepidemiology and pharmacoeconomics in promoting access and stimulating innovation. Pharmacoeconomics 22(Suppl 2):81–86

    Article  PubMed  Google Scholar 

  • Benson K, Hartz AJ (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342:1878–1886

    Article  CAS  PubMed  Google Scholar 

  • Bertoldi AD, Barros AJ, Wagner A, Ross-Degnan D, Hallal PC (2008) A descriptive review of the methodologies used in household surveys on medicine utilization. BMC Health Serv Res 8:222

    Article  PubMed Central  PubMed  Google Scholar 

  • Breslow N (1982) Design and analysis of case-control studies. Annu Rev Public Health 3:29–54

    Article  CAS  PubMed  Google Scholar 

  • Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Sturmer T (2006a) Variable selection for propensity score models. Am J Epidemiol 163(12):1149–1156

    Article  PubMed Central  PubMed  Google Scholar 

  • Brookhart MA, Wang PS, Solomon DH, Schneeweiss S (2006b) Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology 17:268–275

    Article  PubMed Central  PubMed  Google Scholar 

  • Brown JS, Holmes JH, Shah K, Hall K, Lazarus R, Platt R (2010) Distributed health data networks: a practical and preferred approach to multi-institutional evaluations of comparative effectiveness, safety, and quality of care. Med Care 48(6 Suppl):S45–S51

    Article  PubMed  Google Scholar 

  • Brown JS, Kahn M, Toh S (2013) Data quality assessment for comparative effectiveness research in distributed data networks. Med Care 51(8 Suppl 3):S22–S29

    Article  PubMed Central  PubMed  Google Scholar 

  • Chung Y, Lu CY, Graham GG, Mant A, Day RO (2008) Utilization of allopurinol in the Australian community. Intern Med J 38(6):388–395

    Article  CAS  PubMed  Google Scholar 

  • Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887–1892

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Cook NR, Cole SR, Hennekens CH (2002) Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians’ Health Study. Am J Epidemiol 155(11):1045–1053

    Article  PubMed  Google Scholar 

  • Etminan M (2004) Pharmacoepidemiology II: the nested case-control study–a novel approach in pharmacoepidemiologic research. Pharmacotherapy 24:1105–1109

    Article  PubMed  Google Scholar 

  • Farrington CP (2004) Re: “Risk analysis of aseptic meningitis after measles-mumps-rubella vaccination in Korean children by using a case-crossover design”. Am J Epidemiol 159:717–718, author reply 718–720

    Article  CAS  PubMed  Google Scholar 

  • Farrington P, Pugh S, Colville A et al (1995) A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 345:567–569

    Article  CAS  PubMed  Google Scholar 

  • Glynn RJ, Knight EL, Levin R, Avorn J (2001) Paradoxical relations of drug treatment with mortality in older persons. Epidemiology 12(6):682–689

    Article  CAS  PubMed  Google Scholar 

  • Goldacre M (2001) The role of cohort studies in medical research. Pharmacoepidemiol Drug Saf 10:5–11

    Article  CAS  PubMed  Google Scholar 

  • Gram LE, Hallas J, Andersen M (2000) Pharmacovigilance based on prescription databases. Pharmacol Toxicol 86(Suppl 1):13–15

    Article  CAS  PubMed  Google Scholar 

  • Greenland S (2000) An introduction to instrumental variables for epidemiologists. Int J Epidemiol 29:722–729

    Article  CAS  PubMed  Google Scholar 

  • Ho PM, Bryson CL, Rumsfeld JS (2009) Medication adherence: its importance in cardiovascular outcomes. Circulation 119(23):3028–3035

    Article  PubMed  Google Scholar 

  • Hubbard R, Farrington P, Smith C, Smeeth L, Tattersfield A (2003) Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol 158:77–84

    Article  PubMed  Google Scholar 

  • Johnson ES, Bartman BA, Briesacher BA et al (2012) The incident user design in comparative effectiveness research. Effective Health Care Program Research Report No. 32. Agency for Healthcare Research and Quality, Rockville, MD

    Google Scholar 

  • Kelly E, Lu CY, Albertini S, Vitry A (2014) Longitudinal trends in utilization of endocrine therapies for breast cancer: an international comparison. J Clin Pharm Ther. doi:10.1111/jcpt.12227

  • Kush RD, Helton E, Rockhold FW, Hardison CD (2008) Electronic health records, medical research, and the Tower of Babel. N Engl J Med 358(16):1738–1740

    Article  CAS  PubMed  Google Scholar 

  • Lu CY (2009) Pharmacoepidemiologic research in Australia: challenges and opportunities for monitoring patients with rheumatic diseases. Clin Rheumatol 28(4):371–377

    Article  PubMed  Google Scholar 

  • Lu CY, Williams KM, Day RO (2007a) Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme? Intern Med J 37(9):601–606

    Article  CAS  PubMed  Google Scholar 

  • Lu CY, Williams KM, Day RO (2007b) The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines. Aust New Zealand Health Policy 4:2

    Article  PubMed Central  PubMed  Google Scholar 

  • Lu CY, Soumerai SB, Ross-Degnan D, Zhang F, Adams AS (2010) Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness. Med Care 48(1):4–9

    Article  PubMed  Google Scholar 

  • Lu CY, Law MR, Soumerai SB et al (2011) Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study. Clin Ther 33(1):135–144

    Article  PubMed Central  PubMed  Google Scholar 

  • Lu CY, Srasuebkul P, Drew AK, Ward RL, Pearson SA (2012) Positive spillover effects of prescribing requirements: increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer. Intern Med J 42(11):1229–1235

    Article  CAS  PubMed  Google Scholar 

  • Lu CY, Zhang F, Lakoma MD et al (2014) Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study. BMJ 348:g3596

    Article  PubMed Central  PubMed  Google Scholar 

  • Lu CY (2014) Uncertainties in real-world decisions on medical technologies. Int J Clin Pract 68(8):936–940. doi:10.1111/ijcp.12434.

    Article  CAS  PubMed  Google Scholar 

  • Maclure M (1991) The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 133:144–153

    CAS  PubMed  Google Scholar 

  • Maclure M, Fireman B, Nelson JC et al (2012) When should case-only designs be used for safety monitoring of medical products? Pharmacoepidemiol Drug Saf 21(Suppl 1):50–61

    Article  PubMed  Google Scholar 

  • Mamdani M, Sykora K, Li P et al (2005) Reader’s guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 330:960–962

    Article  PubMed Central  PubMed  Google Scholar 

  • McKnight J, Scott A, Menzies D, Bourbeau J, Blais L, Lemiere C (2005) A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. J Clin Epidemiol 58(2):206–208

    Article  PubMed  Google Scholar 

  • McWilliams JM, Meara E, Zaslavsky AM, Ayanian JZ (2007) Use of health services by previously uninsured Medicare beneficiaries. N Engl J Med 357(2):143–153

    Article  CAS  PubMed  Google Scholar 

  • Morgenstern H (1995) Ecologic studies in epidemiology: concepts, principles, and methods. Annu Rev Public Health 16:61–81

    Article  CAS  PubMed  Google Scholar 

  • Motheral BR, Fairman KA (1997) The use of claims databases for outcomes research: rationale, challenges, and strategies. Clin Ther 19(2):346–366

    Article  CAS  PubMed  Google Scholar 

  • Normand SL, Sykora K, Li P, Mamdani M, Rochon PA, Anderson GM (2005) Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding. BMJ 330:1021–1023

    Article  PubMed Central  PubMed  Google Scholar 

  • Organisation for Economic Cooperation and Development (2007) OECD guidelines for quality assurance in genetic testing. http://www.oecd.org/sti/biotech/oecdguidelinesforqualityassuranceingenetictesting.htm

  • Paniz VM, Fassa AG, Maia MF, Domingues MR, Bertoldi AD (2010) Measuring access to medicines: a review of quantitative methods used in household surveys. BMC Health Serv Res 10:146

    Article  PubMed Central  PubMed  Google Scholar 

  • Perrio M, Waller PC, Shakir SA (2007) An analysis of the exclusion criteria used in observational pharmacoepidemiological studies. Pharmacoepidemiol Drug Saf 16(3):329–336

    Article  PubMed  Google Scholar 

  • Psaty BM, Koepsell TD, Lin D et al (1999) Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 47:749–754

    CAS  PubMed  Google Scholar 

  • Robins JM, Hernan MA, Brumback B (2000) Marginal structural models and causal inference in epidemiology. Epidemiology 11(5):550–560

    Article  CAS  PubMed  Google Scholar 

  • Rochon PA, Gurwitz JH, Sykora K et al (2005) Reader’s guide to critical appraisal of cohort studies: 1. Role and design. BMJ 330:895–897

    Article  PubMed Central  PubMed  Google Scholar 

  • Rosenbaum PR, Rubin DB (1984) Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79:516–524

    Article  Google Scholar 

  • Schneeweiss S (2007) Developments in post-marketing comparative effectiveness research. Clin Pharmacol Ther 82(2):143–156

    Article  CAS  PubMed  Google Scholar 

  • Schneeweiss S, Sturmer T, Maclure M (1997) Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf 6(Suppl 3):S51–S59

    Article  PubMed  Google Scholar 

  • Schneeweiss S, Patrick AR, Sturmer T et al (2007) Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care 45(10 Suppl 2):S131–S142

    Article  PubMed Central  PubMed  Google Scholar 

  • Strom BL, Carson JL, Halpern AC et al (1991) Using a claims database to investigate drug-induced Stevens-Johnson syndrome. Stat Med 10(4):565–576

    Article  CAS  PubMed  Google Scholar 

  • United Nations Educational, Scientific and Cultural Organization (2003) International declaration on human genetic data. http://www.unesco.org/new/en/social-and-human-sciences/themes/bioethics/human-genetic-data/

  • Vandenbroucke JP, von Elm E, Altman DG et al (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 18(6):805–835

    Article  PubMed  Google Scholar 

  • Vitry AI, Thai LP, Lu CY (2011) Time and geographical variations in utilization of endocrine therapy for breast cancer in Australia. Intern Med J 41(2):162–166

    Article  CAS  PubMed  Google Scholar 

  • Wettermark B (2013) The intriguing future of pharmacoepidemiology. Eur J Clin Pharmacol 69(Suppl 1):43–51

    Article  PubMed  Google Scholar 

  • Whitaker HJ, Farrington CP, Spiessens B, Musonda P (2006) Tutorial in biostatistics: the self-controlled case series method. Stat Med 25:1768–1797

    Article  PubMed  Google Scholar 

  • Wilchesky M, Tamblyn RM, Huang A (2004) Validation of diagnostic codes within medical services claims. J Clin Epidemiol 57(2):131–141

    Article  PubMed  Google Scholar 

  • World Health Organisation (1993) How to investigate drug use in health facilities: selected drug use indicators – EDM Research Series No. 007. World Health Organisation, Geneva

    Google Scholar 

  • World Health Organisation (2003) Introduction to drug utilization research. World Health Organisation, Geneva

    Google Scholar 

  • World Health Organization (2009) DDD – Definition and General Considerations. http://www.whocc.no/ddd/definition_and_general_considera/. Accessed 25 Feb 2014

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christine Y. Lu .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Lu, C.Y. (2015). Pharmacoepidemiological Approaches in Health Care. In: Babar, ZUD. (eds) Pharmacy Practice Research Methods. Adis, Cham. https://doi.org/10.1007/978-3-319-14672-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-14672-0_11

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-14671-3

  • Online ISBN: 978-3-319-14672-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics